MedPath

Comparing the effect of Drinking and Inhaling of Pushkaramoola distillate for better breathing and Asthma relief.

Phase 2
Conditions
Health Condition 1: J40-J47- Chronic lower respiratory diseasesHealth Condition 2: J454- Moderate persistent asthma
Registration Number
CTRI/2024/07/070713
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects of age group 18-60 years irrespective of their gender and socio-economic

status.

2. Subjects with well and partially controlled Bronchial Asthma (as per Global initiative

for Asthma, Guideline 2023)

3. Subjects with intermittent and mild persistent controlled Bronchial Asthma (FEV1/FVC

between 50% to 79%)

4. Subjects agreeing to provide written informed consent.

Exclusion Criteria

1. Subjects with acute exacerbation

2. Subjects who need rescue medication (e.g., Salbutamol inhaler, etc.)

3. Subjects with evidence of requirement of intubations for Asthma or has been

hospitalized for Asthma within one month before the study commences.

4. Subjects with evidence of malignancy and cardiovascular disease

5. Subjects with other respiratory disorders like Interstitial Lung Disease, Bronchiectasis,

COPD, Tuberculosis, Cystic Fibrosis.

6. Airway obstruction from mass or foreign body

7. Autoimmune disease like Rheumatoid and Sero-Negative Arthritis

8. Smokers

9. Pregnant or lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath